Irish biotech startup Aerska secured $39M in funding to develop technology that delivers RNA-based medicines across the blood-brain barrier. The company aims to treat neurodegenerative diseases like Alzheimer's and Parkinson's by targeting disease-causing proteins at their genetic source, rather than just managing symptoms. The
Sort: